Preclinical Safety Testing of Biotechnology-Derived Pharmaceuticals: Understanding the Issues and Addressing the Challenges

Author： Brennan Frank R.   Shaw Leigh   Wing Mark G.   Robinson Christine  

Publisher： Humana Press, Inc

ISSN： 1073-6085

Source： Molecular Biotechnology, Vol.27, Iss.1, 2004-05, pp. : 59-74

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanism of action and therapeutic efficacy of the biotechnology-derived immunostimulating extract OM-85 in respiratory tract infections

By Meredith Marit   Chiavaroli Carlo  

International Journal of Biotechnology, Vol. 9, Iss. 3-4, 2007-06 ,pp. : 344-359

Inderscience Publishers

Access to resources Recommend Favorite

The quest for generic biotechnology pharmaceuticals in the USA

By Kowalski Thomas J   Fekete Pamela   Yvon Anne-Marie C  

Journal of Commercial Biotechnology, Vol. 11, Iss. 3, 2005-04 ,pp. : 271-274

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Anticipating and managing the challenges of biotechnology marketing

By Rajamäki Heidi  

Journal of Commercial Biotechnology, Vol. 14, Iss. 3, 2008-07 ,pp. : 225-231

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Preclinical and safety studies of V-1 Immunitor

By Jirathitikal Vichai   Bourinbaiar Aldar S.  

International Journal of Biotechnology, Vol. 9, Iss. 3-4, 2007-06 ,pp. : 318-331

Inderscience Publishers

Access to resources Recommend Favorite

Recent progress and new challenges in metagenomics for biotechnology

By Chistoserdova Ludmila  

Biotechnology Letters, Vol. 32, Iss. 10, 2010-10 ,pp. : 1351-1359

Springer Publishing Company

Access to resources Recommend Favorite